Antibody Recognition of a Highly Conserved Influenza Virus Epitope

被引:1081
作者
Ekiert, Damian C. [1 ]
Bhabha, Gira [1 ]
Elsliger, Marc-Andre [1 ]
Friesen, Robert H. E. [2 ]
Jongeneelen, Mandy [2 ]
Throsby, Mark [2 ]
Goudsmit, Jaap [2 ]
Wilson, Ian A. [1 ,3 ]
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Crucell Holland BV, NL-2301 CA Leiden, Netherlands
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
A VIRUSES; MEMBRANE-FUSION; HIV-1; NEUTRALIZATION; STRUCTURAL BASIS; AVIAN INFLUENZA; BINDING SITE; HEMAGGLUTININ; RECEPTOR; COMPLEX; PH;
D O I
10.1126/science.1171491
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 39 条
[1]   An antibody that prevents the hemagglutinin low pH fusogenic transition [J].
Barbey-Martin, C ;
Gigant, B ;
Bizebard, T ;
Calder, LJ ;
Wharton, SA ;
Skehel, JJ ;
Knossow, M .
VIROLOGY, 2002, 294 (01) :70-74
[2]   EVOLUTION OF THE H3 INFLUENZA-VIRUS HEMAGGLUTININ FROM HUMAN AND NONHUMAN HOSTS [J].
BEAN, WJ ;
SCHELL, M ;
KATZ, J ;
KAWAOKA, Y ;
NAEVE, C ;
GORMAN, O ;
WEBSTER, RG .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1129-1138
[3]   Current and future antiviral therapy of severe seasonal and avian influenza [J].
Beigel, John ;
Bray, Mike .
ANTIVIRAL RESEARCH, 2008, 78 (01) :91-102
[4]   Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States [J].
Bright, RA ;
Shay, DK ;
Shu, B ;
Cox, NJ ;
Klimov, AI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (08) :891-894
[5]   STRUCTURE OF INFLUENZA HEMAGGLUTININ AT THE PH OF MEMBRANE-FUSION [J].
BULLOUGH, PA ;
HUGHSON, FM ;
SKEHEL, JJ ;
WILEY, DC .
NATURE, 1994, 371 (6492) :37-43
[6]   Antibody vs. HIV in a clash of evolutionary titans [J].
Burton, DR ;
Stanfield, RL ;
Wilson, IA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) :14943-14948
[7]   N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA2 subunit to form an N cap that terminates the triple-stranded coiled coil [J].
Chen, J ;
Skehel, JJ ;
Wiley, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8967-8972
[8]   STRUCTURAL REPERTOIRE OF THE HUMAN V(H) SEGMENTS [J].
CHOTHIA, C ;
LESK, AM ;
GHERARDI, E ;
TOMLINSON, IM ;
WALTER, G ;
MARKS, JD ;
LLEWELYN, MB ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 227 (03) :799-817
[9]   The evolutionary and structural 'logic' of antigen receptor diversity [J].
Davis, MM .
SEMINARS IN IMMUNOLOGY, 2004, 16 (04) :239-243
[10]   A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site [J].
Fleury, D ;
Barrère, B ;
Bizebard, T ;
Daniels, RS ;
Skehel, JJ ;
Knossow, M .
NATURE STRUCTURAL BIOLOGY, 1999, 6 (06) :530-534